PDF herunterladen
Synthesis 2001(13): 1965-1970
DOI: 10.1055/s-2001-17703
PAPER
© Georg Thieme Verlag Stuttgart · New York

A Novel Convenient Synthesis of 1,3,4-Oxadiazol-2-ones and -thiones from N-tert-Butyldiacylhydrazines

Mark J. Mulvihill*, Duyan V. Nguyen, Brian S. MacDougall, Damian G. Weaver, William D. Mathis
Rohm and Haas Company, 727 Norristown Road, Spring House, Pennsylvania, 19477, USA
Fax: +1(914)3453565; e-Mail: mark.mulvihill@osip.com;
Weitere Informationen

Publikationsverlauf

Received 4 May 2001
Publikationsdatum:
10. August 2004 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

An attractive, novel, convenient process for the preparation of 3,5-disubstituted-3H-[1,3,4]-oxadiazol-2-ones and -thiones from the reaction of various equivalent and non-equivalent N-tert-butyldiacylhydrazines with potassium tert-butoxide followed by treatment with phosgene or thiophosgene, respectively, has been discovered. The 3,5-disubstituted-3H-[1,3,4]-oxadiazol-2-ones and -thiones are confirmed both analytically and chemically. Various equivalent and non-equivalent N-tert-butyldiacylhydrazines are conveniently synthesized from the reaction of tert-butylhydrazine hydrochloride in the presence of i-Pr2NEt, with acid chloride #1 followed by subsequent treatment with acid chloride #2. Both the syntheses of 3,5-disubstituted-3H-[1,3,4]-oxadiazol-2-ones and -thiones, as well as N-tert-butyldiacylhydrazines, are easily performed on multigram scales.

Key words

cyclization - heterocycles - regioselectivity - hydrazine - phosgene

    References

  • 2a Lidert Z, Le DP, Hormann RE, and Opie TR. inventors; US Patent  5530028. 
  • 3a James WNJr, and Aller HE. inventors; US Patent  5358966. 
  • 4 Thomson WT. Agricultural Chemicals, Book 1, Insecticides   Thomson Publications; Fresno, CA: 1998.  14th ed.. p.142-144  
  • 5a Huang LJ. Kuo SC. Wang JP. Ishii K. Nakamura H. Chem. Pharm. Bull.  1994,  41:  2036 
    Suche in Google Scholar
  • 5b Hazarika J. Kataky JCS. Ind. J. Heterocycl. Chem.  1997,  7:  47 
    Suche in Google Scholar
  • 5c Musser JH. Brown RE. Loev B. Bailey K. Jones H. Kahen R. Huang F. Khandwala A. Leibowitz M. J. Med. Chem.  1984,  27:  121 
    Suche in Google Scholar
  • 5d Khandwala A. Coutts S. Dally-Meade V. Jariwala N. Musser J. Brown R. Jones H. Loev B. Weinryb I. Biochem. Pharmacol.  1983,  32:  3325 
    Suche in Google Scholar
  • 5e Singh H. Yadav LDS. Bhattacharya BK. J. Ind. Chem. Soc.  1980,  57:  1006 
    Suche in Google Scholar
  • 5f Meyer RF. Cummings BL. J. Heterocycl. Chem.  1964,  1:  186 
    Suche in Google Scholar
  • 6a Squillacote M. Felippis JD. J. Org. Chem.  1994,  59:  3564 
    Suche in Google Scholar
  • 6b Saegusa Y. Nakamura S. Chau N. Iwakura Y. J. Polym. Sci.  1983,  21:  637 
    Suche in Google Scholar
  • 7 Gogoi PC. Kataky JCS. Heterocycles  1991,  32:  237 
    Suche in Google Scholar
  • 9a Kelley MJ, and Budenz AM. inventors; US Patent  5675037. 
1

Tebufenozide (1a) is commercially available.

8

We decided to further chemically validate the structure of 4a utilizing Gogoi’s method [7] for the synthesis of 3,5-disubsti-tuted-3H-[1,3,4]-oxadiazol-2-ones. We synthesized N’-(3,5-dimethylbenzoyl)hydrazinecarboxylic acid ethyl ester from the reaction of a CH2Cl2 solution of ethyl carbazate with 3,5-dimethylbenzoyl chloride in the presence of i-Pr2NEt. Reaction of N’-(3,5-dimethylbenzoyl)hydrazinecarboxylic acid ethyl ester with POCl3 afforded 5-(3,5-dimethylphenyl)-3H-[1,3,4]-oxadiazol-2-one (7), which was analytically identical to compound 7 synthesized via Scheme [2] (Table [2] ). Benzoylation of 7 with 4-ethylbenzoyl chloride afforded 5-(3,5-dimethylphenyl)-3-(4-ethylbenozyl)-3H-[1,3,4]-oxadiazol-2-one (4a), which was identical in all respects to 4a synthesized via our phosgene/N-tert-butyldiacylhydrazine route.